ArticleJournal of ovarian research2025

Unbiased combination screening on repurposed drugs reveals synergistic potential of copanlisib and cerivastatin against chemoresistant high-grade serous ovarian cancer.

Yu Sun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.